Determining the correct retatrutide regimen is vitally important for seeing desired outcomes . Initially, patients typically begin with a introductory amount of approximately 2.4 mg, given each week via subcutaneous . This preliminary quantity is then incrementally raised every four periods, until a maximum dose of 10.8 mg, according to person rea